Celon Pharma S.A.
WSE:CLN.WA
15.96 (PLN) • At close December 14, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) PLN.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 50.747 | 53.582 | 36.318 | 40.66 | 42.5 | 42.228 | 39.006 | 44.156 | 38.995 | 45.842 | 32.922 | 39.186 | 37.763 | 49.153 | 43.457 | 38.875 | 30.457 | 39.088 | 30.858 | 26.99 | 23.999 | 24.168 | 27.091 | 35.142 | 31.696 | 30.24 | 28.167 | 25.911 | 24.21 | 28.611 | 28.387 | 47.533 | 22.391 | 30.038 | 41.822 | 29.991 | 28.485 |
| Cost of Revenue
| 17.79 | 17.224 | 53.545 | 16.015 | 16.33 | 16.168 | 16.305 | 18.688 | 15.219 | 19.583 | 12.972 | 19.821 | 8.674 | 17.373 | 13.612 | 9.939 | 7.276 | 9.435 | 10.477 | 5.424 | 5.599 | 8.475 | 3.856 | 5.655 | 8.858 | 7.185 | 6.478 | 3.006 | 6.991 | 7.262 | 7.207 | 5.555 | 7.23 | 6.633 | 9.06 | 11.173 | 15.334 |
| Gross Profit
| 32.957 | 36.358 | -17.227 | 24.645 | 26.17 | 26.06 | 22.701 | 25.468 | 23.776 | 26.259 | 19.95 | 19.365 | 29.089 | 31.78 | 29.845 | 28.936 | 23.181 | 29.653 | 20.381 | 21.565 | 18.4 | 15.693 | 23.234 | 29.487 | 22.838 | 23.055 | 21.689 | 22.905 | 17.219 | 21.349 | 21.181 | 41.978 | 15.16 | 23.404 | 32.762 | 18.818 | 13.151 |
| Gross Profit Ratio
| 0.649 | 0.679 | -0.474 | 0.606 | 0.616 | 0.617 | 0.582 | 0.577 | 0.61 | 0.573 | 0.606 | 0.494 | 0.77 | 0.647 | 0.687 | 0.744 | 0.761 | 0.759 | 0.66 | 0.799 | 0.767 | 0.649 | 0.858 | 0.839 | 0.721 | 0.762 | 0.77 | 0.884 | 0.711 | 0.746 | 0.746 | 0.883 | 0.677 | 0.779 | 0.783 | 0.627 | 0.462 |
| Reseach & Development Expenses
| 0 | 0 | 0.68 | 0.68 | 0 | 0 | 0 | 62.319 | 0 | 0 | 0 | 49.054 | 0 | 0 | 8.339 | 42.254 | 0 | 0 | 10.358 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.676 | 10.856 | 12.622 | 7.851 | 10.138 | 2.176 | 2.412 | 2.365 | 9.941 | 7.954 | 4.951 | 3.546 | 3.735 | 3.646 | 4.345 | 4.967 | 4.617 | 4.407 | 0.89 | 5.042 | 5.963 | 6.789 | 5.966 | 4.392 | 4.232 | 5.422 | 36.418 | 8.964 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.334 | 4.281 | 7.58 | 4.119 | 3.936 | 3.898 | 11.426 | 3.339 | 8.087 | 0 | 13.07 | 3.427 | 9.643 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 0 | 34.053 | 4.6 | 29.923 | 2.131 | 4.756 | 28.675 | 5.514 | 2.304 | 12.676 | 10.856 | 12.622 | 7.851 | 10.138 | 2.176 | 2.412 | 2.365 | 9.941 | 4.281 | 4.951 | 3.546 | 3.735 | 3.646 | 4.345 | 4.967 | 4.617 | 4.407 | 0.89 | 5.042 | 5.963 | 6.789 | 5.966 | 4.392 | 4.232 | 5.422 | 36.418 | 8.964 |
| Other Expenses
| -23.724 | 21.165 | 0.143 | 0.36 | 0.376 | 0.987 | 36.591 | 31.338 | 35.545 | 22.15 | 20.207 | 12.744 | 27.609 | 20.114 | 18.948 | 12.526 | 19.014 | 12.279 | -1.249 | 17.941 | 13.487 | 12.366 | 13.001 | 14.979 | 9.831 | 9.285 | 9.304 | 12.885 | 7.935 | 7.757 | 9.367 | 29.227 | 2.405 | 10.253 | 8.188 | 0 | 0 |
| Operating Expenses
| -23.724 | 55.218 | 4.6 | 35.096 | 36.684 | 14.904 | 36.591 | 31.338 | 35.545 | 34.826 | 31.063 | 25.366 | 35.46 | 30.252 | 29.463 | 14.938 | 21.38 | 25.554 | 10.986 | 22.892 | 17.033 | 16.102 | 16.647 | 19.324 | 14.798 | 13.902 | 13.71 | 13.776 | 12.977 | 13.721 | 16.157 | 35.193 | 6.797 | 14.486 | 13.61 | 30.092 | 8.257 |
| Operating Income
| 56.681 | -6.819 | -21.827 | -9.276 | -9.768 | 11.418 | -13.89 | -3.474 | -11.05 | -7.919 | -11.078 | -5.992 | -6.371 | 1.528 | 0.382 | 0.149 | 1.909 | 4.097 | 9.638 | -1.15 | 1.616 | -0.247 | 6.679 | 10.248 | 8.084 | 9.214 | 8.066 | 8.945 | 4.242 | 7.711 | 5.093 | 6.098 | 8.806 | 8.946 | 19.218 | 27.155 | 4.165 |
| Operating Income Ratio
| 1.117 | -0.127 | -0.601 | -0.228 | -0.23 | 0.27 | -0.356 | -0.079 | -0.283 | -0.173 | -0.336 | -0.153 | -0.169 | 0.031 | 0.009 | 0.004 | 0.063 | 0.105 | 0.312 | -0.043 | 0.067 | -0.01 | 0.247 | 0.292 | 0.255 | 0.305 | 0.286 | 0.345 | 0.175 | 0.27 | 0.179 | 0.128 | 0.393 | 0.298 | 0.46 | 0.905 | 0.146 |
| Total Other Income Expenses Net
| 1.205 | -3.531 | 5.023 | 1.866 | 1.699 | 1.676 | 2.315 | 1.452 | 0.159 | -0.147 | -0.574 | -1.121 | -1.729 | 0.322 | -2.106 | -0.919 | -0.274 | -0.698 | 0.027 | 0.052 | 0.115 | 0.322 | 0.422 | 0.439 | 0.284 | 0.242 | 0.917 | 1.094 | 1.06 | 2.022 | 0.746 | 0.172 | -0.441 | -0.052 | -0.211 | -36.084 | 0.551 |
| Income Before Tax
| 57.886 | -10.35 | -12.857 | -7.41 | -8.069 | 13.094 | -11.575 | -4.843 | -11.401 | -8.529 | -11.672 | -7.113 | -8.1 | 1.849 | -1.724 | -0.77 | 1.635 | 3.399 | 9.641 | -1.098 | 1.731 | 0.075 | 7.101 | 10.687 | 8.368 | 9.456 | 8.982 | 10.038 | 5.302 | 9.734 | 5.839 | 6.269 | 8.364 | 8.894 | 19.007 | 11.116 | 4.738 |
| Income Before Tax Ratio
| 1.141 | -0.193 | -0.354 | -0.182 | -0.19 | 0.31 | -0.297 | -0.11 | -0.292 | -0.186 | -0.355 | -0.182 | -0.214 | 0.038 | -0.04 | -0.02 | 0.054 | 0.087 | 0.312 | -0.041 | 0.072 | 0.003 | 0.262 | 0.304 | 0.264 | 0.313 | 0.319 | 0.387 | 0.219 | 0.34 | 0.206 | 0.132 | 0.374 | 0.296 | 0.454 | 0.371 | 0.166 |
| Income Tax Expense
| 0.711 | -2.325 | 2.814 | 7.559 | -1.254 | 3.951 | -2.1 | 7.142 | 0.268 | -0.419 | -4.16 | -3.034 | -0.269 | -0.168 | -0.009 | 2.458 | -2.33 | -0.062 | 0.228 | -2.74 | -0.402 | -1.595 | 0.611 | 3.84 | 0.746 | 1.868 | 1.433 | 4.173 | 1.52 | 1.323 | 0.817 | 3.536 | 1.163 | 1.641 | 3.531 | 3.838 | 0.653 |
| Net Income
| 57.175 | -8.025 | -15.671 | -14.969 | -6.815 | 9.143 | -9.475 | -11.985 | -11.669 | -8.11 | -7.512 | -4.079 | -7.831 | 2.017 | -1.715 | -3.228 | 3.965 | 3.46 | 9.413 | 1.641 | 2.133 | 1.67 | 6.49 | 6.268 | 8.291 | 7.588 | 7.55 | 6.243 | 4.924 | 8.411 | 5.021 | 2.733 | 7.201 | 7.254 | 15.476 | 7.278 | 4.085 |
| Net Income Ratio
| 1.127 | -0.15 | -0.431 | -0.368 | -0.16 | 0.217 | -0.243 | -0.271 | -0.299 | -0.177 | -0.228 | -0.104 | -0.207 | 0.041 | -0.039 | -0.083 | 0.13 | 0.089 | 0.305 | 0.061 | 0.089 | 0.069 | 0.24 | 0.178 | 0.262 | 0.251 | 0.268 | 0.241 | 0.203 | 0.294 | 0.177 | 0.058 | 0.322 | 0.241 | 0.37 | 0.243 | 0.143 |
| EPS
| 1.06 | -0.15 | -0.31 | -0.29 | -0.13 | 0.18 | -0.19 | -0.23 | -0.23 | -0.16 | -0.15 | -0.13 | -0.17 | 0.01 | -0.04 | -0.072 | 0.088 | 0.08 | 0.21 | 0.037 | 0.05 | 0.037 | 0.14 | 0.14 | 0.18 | 0.17 | 0.17 | 0.14 | 0.11 | 0.19 | 0.11 | 0.061 | 0.16 | 0.24 | 0.34 | 0.24 | 0.14 |
| EPS Diluted
| 1.06 | -0.15 | -0.31 | -0.29 | -0.13 | 0.18 | -0.19 | -0.23 | -0.23 | -0.16 | -0.15 | -0.1 | -0.17 | 0.01 | -0.04 | -0.072 | 0.088 | 0.08 | 0.21 | 0.037 | 0.05 | 0.037 | 0.14 | 0.14 | 0.18 | 0.17 | 0.17 | 0.14 | 0.11 | 0.19 | 0.11 | 0.061 | 0.16 | 0.24 | 0.34 | 0.24 | 0.14 |
| EBITDA
| 71.514 | 2.759 | -9.098 | 5.938 | 5.328 | 25.459 | 0.965 | 4.96 | 0.747 | 3.313 | 0.586 | 0.578 | 6.187 | 12.389 | 7.866 | 9.197 | 8.662 | 12.151 | 3.424 | 4.222 | 7.018 | 5.365 | 11.531 | 14.212 | 12.777 | 14.591 | 13.315 | 15.986 | 9.369 | 13.678 | 9.623 | 9.286 | 11.857 | 13.602 | 20.939 | 29.197 | 5.453 |
| EBITDA Ratio
| 1.409 | 0.051 | -0.251 | 0.146 | 0.125 | 0.603 | 0.025 | 0.112 | 0.019 | 0.072 | 0.018 | 0.015 | 0.164 | 0.252 | 0.181 | 0.237 | 0.284 | 0.311 | 0.111 | 0.156 | 0.292 | 0.222 | 0.426 | 0.404 | 0.403 | 0.483 | 0.473 | 0.617 | 0.387 | 0.478 | 0.339 | 0.195 | 0.53 | 0.453 | 0.501 | 0.974 | 0.191 |